Combination therapies for b-cell lymphomas comprising administration of Anti-cd20 antibody
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- GRILLO LOPEZ ANTONIO J
- Publication Date
- 2012-10-04
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a divisional application of U.S. patent application Ser. No. 11 / 840,956, filed Aug. 18, 2007, which is a continuation of U.S. patent application Ser. No. 10 / 196,732, filed Jul. 17, 2002 (abandoned), which is a continuation of U.S. patent application Ser. No. 09 / 372,202, filed Aug. 11, 1999, (now U.S. Pat. No. 6,455,043) which claims priority under 35 U.S.C. Section 119(e) and the benefit of U.S. Provisional Application Ser. No. 60 / 096,180 filed Aug. 11, 1998, the disclosures of which are incorporated herein by reference in their entireties.FIELD OF THE INVENTION
[0002] The invention relates to the use of anti-CD20 antibodies or fragments thereof in the treatment of B-cell lymphomas, particularly the use of such antibodies and fragments in combined therapeutic regimens.BACKGROUND OF THE INVENTION
[0003] The use of antibodies to the CD20 antigen as diagnostic and / or therapeutic agents for B-cell lymphoma has previously been ...